EP Patent

EP4061352A4 — Compounds and methods of preparing compounds s1p1 modulators

Assigned to Trevena Inc · Expires 2024-02-28 · 2y expired

What this patent protects

Patent listed against Velsipity.

Drugs covered by this patent

Velsipity (Etrasimod Arginine) · Pfizer Inc.

Patent Metadata

Patent number: EP4061352A4
Jurisdiction: EP
Classification: —
Expires: 2024-02-28
Drug substance claim: No
Drug product claim: No
Assignee: Trevena Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.